Acta Chir Orthop Traumatol Cech. 2019; 86(1):51-57 | DOI: 10.55095/achot2019/008

Mid-Term Outcomes of Reconstruction of Charcot Foot Neuroarthropathy in Diabetic PatientsOriginal papers

T. KUČERA*, M. GRINAC, O. VALTR, P. ©PONER
Ortopedická klinika Fakultní nemocnice a Lékařské fakulty Univerzity Karlovy, Hradec Králové

PURPOSE OF THE STUDY:
The aim of this study was to evaluate the mid-term outcomes of the surgical reconstruction of Charcot Foot Neuroarthropathy in diabetic patients with failed conservative treatment and indicated for a below-knee amputation.

MATERIAL AND METHODS:
In the period from 2010 to 2015 the surgical reconstruction of inactive, chronic Charcot Foot Neuroarthropathy classified as type II and III by Sanders and Frykbeg was performed in 16 patients with failed conservative treatment. All these patients were by the diabetes centres initially indicated for a below-knee amputation. The performed evaluation focused on the clinical outcome (limb preservation, walking in footwear, full weight-bearing capability, the radiographic result (talar-first metatarsal angle, calcaneal inclination - negative, neutral, positive), complications (associated and not associated with the surgery).

RESULTS:
The mean follow-up period was 4.7 years (2.5-7.5 years). From the original group of 16 patients indicated for a below-knee amputation following the failure of conservative treatment, the amputation was performed in one patient only. After the surgical reconstruction 15 patients were able to fully weight-bear when achieving plantigrade foot position, of whom 9 wore regular footwear and 6 customised diabetic footwear. The talar-first metatarsal angle was corrected from the mean 30 degrees (20-45) to the mean 5 degrees (0-10). The calcaneal inclination was corrected from the negative preoperative value in all the cases to neutral in 5 patients and positive in 10 patients. The surgery-associated complications were the following: infectious complications - positive preoperative cultivation in 10 out of 16 patients, secondary healing of the surgical wound in 7 patients, the need of additional ablation of plantar prominence of tarsal skeleton in 2 patients, screw prominence in 2 patients with the need of extraction - all healed without complications. In one case a lower limb amputation was performed due to secondary limb ischemia. The complications not associated with the surgery consisted of a soft tissue injury due to neuropathy.

DISCUSSION:
Conservative treatment remains the basic approach to Charcot foot neuroarthropathy which is often associated with a long-term off-loading of the affected limb on a wheelchair, repeated hospital stays, changes of wound dressing of plantar ulcers. These are stated as the most frequent indications for a major amputation. Nonetheless, even the major amputation is accompanied by complications. The candidate for a reconstruction surgery should be a cooperating, compensated, informed diabetic patient with Charcot foot neuroarthropathy, either instable or stable, but non-plantigrade. It is necessary to diagnose and treat the impairment of leg blood supply and osteomyelitis, and to provide an appropriate rehabilitation.

CONCLUSIONS:
Of the original 16 indications for a lower limb amputation in diabetic patients with Charcot foot neuroarthropathy, only one amputation was performed. Positive mid-term outcomes of surgical reconstruction justify further development of this method, bearing in mind the necessity of careful indication and preoperative preparation of the patient in cooperation with diabetologists. Precise and accurate surgical technique and relevant postoperative care are essential to minimise the potential complications.

Keywords: Charcot arthropathy, diabetic neuropathy, rocker-bottom foot deformity, foot reconstruction

Published: February 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
KUČERA T, GRINAC M, VALTR O, ©PONER P. Mid-Term Outcomes of Reconstruction of Charcot Foot Neuroarthropathy in Diabetic Patients. Acta Chir Orthop Traumatol Cech. 2019;86(1):51-57. doi: 10.55095/achot2019/008. PubMed PMID: 30843514.
Download citation

References

  1. Assal M, Stern R. Realignment and extended fusion with use of a medial column screw for midfoot deformities secondary to diabetic neuropathy. J Bone Jt Surg Am. 2009;91:812-820. Go to original source... Go to PubMed...
  2. Botek G, Anderson MA, Taylor R. Charcot neuroarthropathy: an often overlooked complication of diabetes. Cleve Clin J Med. 2010;77:593-599. Go to original source... Go to PubMed...
  3. Broulíková A. Syndrom diabetické nohy - diagnostika a léčba. Interní Med. 2013;15:84-86.
  4. Butt DA, Hester T, Bilal A, Edmonds M, Kavarthaou V. The medial column Synthes Midfoot Fusion Bolt is associated with unacceptable rates of failure in corrective fusion for Charcot deformity: results from a consecutive case series. J Bone Joint Surg Am. 2015;97:809-813. Go to original source... Go to PubMed...
  5. Ertugrul BM, Lipsky BA, Savk O. Osteomyelitis or Charcot neuroosteoarthropathy? Differentiating these disorders in diabetic patients with a foot problém. Diabet Foot Ankle. 2013;4:doi: 10.3402/dfa.v4i0.21855. Go to original source... Go to PubMed...
  6. Eschler A, Wussow A, Ulmar B, Mittlmeier T, Grandl G. Intramedullary medial column support with the Midfoot Fusion Bolt (MFB) is not sufficient for osseous healing of arthrodesis in neuroosteoarthropathic feet. Injury. 2014;45(1 Suppl):S38-43. Go to original source... Go to PubMed...
  7. Frykberg RG, Belczyk R. Epidemiology of the Charcot foot. Clin Podiatr Med Surg. 2008;25:17-28. Go to original source... Go to PubMed...
  8. Güven MF, Karabiber A, Kaynak G, Oğüt T. Conservative and surgical treatment of the chronic Charcot foot and ankle. Diabet Foot Ankle. 2013;4:doi org/10 3402/dfa v4i0 21177. Go to original source... Go to PubMed...
  9. Charcot JM. Sur quelques arthropathies qui paraissent dependre d une lesion du cerveau ou de la moelle epimere. Arch Physiol Norm Pathol. 1868;1:161.
  10. Jordan WR. Neuritic manifestations in diabetes mellitus. Arch Intern Med. 1936;57:307-366. Go to original source...
  11. Koller A, Springfeld R, Engels G, Fiedler R, Orthner E, Schrinner S, Sikorski A. German-Austrian consensus on operative treatment of Charcot neuroarthropathy: a perspective by the Charcot task force of the German association for foot surgery. Diabet Foot Ankle. 2011;2: doi: 10.3402/dfa.v2i0.10207. Go to original source... Go to PubMed...
  12. Milne TE, Rogers JR, Kinnear EM, Martin HV, Lazzarini PA, Quinton TR, Boyle FM. Developing an evidence-based clinical pathway for the assessment diagnosis and management of acute Charcot neuro-arthropathy: a systematic review. J Foot Ankle Res. 2013;6:30. Go to original source... Go to PubMed...
  13. Munson ME, Wrobel JS, Holmes CM, Hanauer DA. Data mining for identifying novel associations and temporal relationships with Charcot foot. J Diabetes Res. 2014;2014:214353. doi org/10 1155/2014/214353. Go to original source... Go to PubMed...
  14. Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45:1085-1096. Go to original source... Go to PubMed...
  15. Ramanujam CL, Facaros Z. An overview of conservative treatment options for diabetic Charcot foot neuroarthropathy. Diabet Foot Ankle. 2011;2:10.3402/dfa.v2i0.6418. Go to original source... Go to PubMed...
  16. Rogers LC, Frykberg RG, Armstrong DG, Boulton AJM, Edmonds M, Ha Van G, Hartemann A, Game F, Jeffcoate W, Jirkovska A, Jude E, Morbach S, Morrison WB, Pinzur M, Pitocco D, Sanders L, Wukich DK, Uccioli L. The Charcot foot in diabetes. Diabetes Care. 2011;34:2123-2129. Go to original source... Go to PubMed...
  17. Saltzman CL, Hagy ML, Zimmerman B, Estin M, Cooper R. How effective is intensive nonoperative initial treatment of patiens with diabetes and Charcot arthropathy of the feet?. Clin Orthop Relat Res. 2005;435:185-190. Go to original source... Go to PubMed...
  18. Samann A, Pofahl S, Lehmann T, Vigt B, Victor S, Moller F, Muller UA, Wolf G. Diabetic nephropathy but not HbA1c is predictive for frequent complications of Charcot feet - lon-term follow-up of 164 consecutive patients with 195 acute Charcot feet. Exp Clin Endocrinal Diabetes. 2012;120:335-339. Go to original source... Go to PubMed...
  19. Sammarco VJ. Superconstructs in the treatment of Charcot foot deformity: plantar plating locked plating and axial screw fixation. Foot Ankle Clin. 2009;14:393-407. Go to original source... Go to PubMed...
  20. Sanders LJ, Frykberg RG. Diabetic neuropathic osteoarthropathy:the Charcot foot. In: Frykberg RG (ed). The high risk foot in diabetes mellitus. Churchill Livingstone, New York, 1993, pp.297-336.
  21. Sanverdi SE, Ergen FB, Oznur A. Current challenges in imaging of the diabetic foot. Diabet Foot Ankle. 2012; 3:doi:10.3402/dfa.v3i0.18754. Go to original source... Go to PubMed...
  22. Sohn MW, Lee TA, Stuck RM, Frykberg RG, Budiman-Mak E. Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and that of diabetes alone. Diab Care. 2009;32:816-821. Go to original source... Go to PubMed...
  23. Wunschel M, Wulker N, Gesicky M. Charcot artrhropathy of the first metatarsophalangeal joint. J Am Podiatr Med Assoc. 2012;102:161-164. Go to original source... Go to PubMed...
  24. Zgonis T. Surgical reconstruction of the diabetic foot and ankle. Lippincott Williams and Wilkins, Philadelphia, 2009.